Market Research Logo

Stratatech Corporation - Product Pipeline Analysis, 2016 Update

Summary:

Stratatech Corporation (Stratatech) is a regenerative medicine company offers skin regeneration therapies. The company offers ExpressGraft genetically enhanced skin tissues and StrataGraft skin tissues. Its StrataGraft skin tissues provide mimic natural human skin, with both dermal and fully differentiated epidermal layers that is used in severe burns and other complex skin defects. The company provides skin regeneration therapies for severe burns and other rare diseases, and chronic non-healing ulcers. Its ExpressGraft genetically enhanced skin tissues provide therapeutic proteins that offer protection and modulation of local wound microenvironment, fight infection, and accelerate healing. Stratatech is headquartered in Madison, Wisconsin, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Stratatech Corporation
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Table of Contents
List of Tables
List of Figures
Stratatech Corporation Company Snapshot
Stratatech Corporation Company Overview
Key Information
Stratatech Corporation Pipeline Products and Clinical Trials Overview
Stratatech Corporation - Major Products and Services
Stratatech Corporation Pipeline Products by Development Stage
Stratatech Corporation Pipeline Products Overview
EpiReady
EpiReady Product Overview
ExpressGraft - Antineoplastic
ExpressGraft - Antineoplastic Product Overview
ExpressGraft - Sclerotic Digital Ulcers
ExpressGraft - Sclerotic Digital Ulcers Product Overview
ExpressGraft Antimicrobial - Diabetic Foot Ulcers
ExpressGraft Antimicrobial - Diabetic Foot Ulcers Product Overview
ExpressGraft Antimicrobial - Venous Leg Ulcers
ExpressGraft Antimicrobial - Venous Leg Ulcers Product Overview
ExpressGraft Pro-Angeogenic - Venous Leg Ulcers
ExpressGraft Pro-Angeogenic - Venous Leg Ulcers Product Overview
ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers
ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers Product Overview
ExpressGraftEnhance Tissue
ExpressGraftEnhance Tissue Product Overview
StrataGraft - Epidermolysis Bullosa
StrataGraft - Epidermolysis Bullosa Product Overview
StrataGraft - Scar Revision
StrataGraft - Scar Revision Product Overview
StrataGraft - Scleroderma Digital Ulcers
StrataGraft - Scleroderma Digital Ulcers Product Overview
StrataGraft - Severe Burns
StrataGraft - Severe Burns Product Overview
Stratatech Corporation - Key Competitors
Stratatech Corporation - Key Employees
Stratatech Corporation - Locations And Subsidiaries
Head Office
Recent Developments
Stratatech Corporation, Recent Developments
Oct 05, 2015: Stratatech Awarded BARDA Project BioShield Contract Valued up to $247 Million for StrataGraft Skin Tissue for Thermal Burns
Mar 10, 2015: Stratatech Announces Positive Top-Line Results from Proof-of-Concept Study of StrataGraft Skin Tissue in Patients with Severe Burns
Jul 31, 2013: Stratatech Awarded BARDA Contract Valued up to $47.2 Million for Advanced Development of StrataGraft Skin Tissue for Thermal Burns
Jan 16, 2013: Stratatech Announces Impressive Clinical Results For StrataGraft Skin Tissue
Jun 13, 2012: Stratatech’s StrataGraft Skin Substitute Receives FDA Orphan Drug Designation
Apr 27, 2012: Stratatech Reports Positive Interim Clinical Results For StrataGraft Skin Substitute
Sep 23, 2011: Stratatech Initiates Second Clinical Trial Of StrataGraft Skin Substitute
Dec 13, 2010: Stratatech Appoints Russell Smestad As president
Nov 16, 2010: Stratatech Receives $3.5 Million To Continue Development Of ExpressGraftEnhance Tissue
Jan 11, 2010: Stratatech To Collaborate With Fortune 200 Company On Product Development
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Stratatech Corporation, Key Facts
Stratatech Corporation Pipeline Products and Clinical Trials Overview
Stratatech Corporation Pipeline Products by Equipment Type
Stratatech Corporation Pipeline Products by Indication
Stratatech Corporation, Major Products and Services
Stratatech Corporation Number of Pipeline Products by Development Stage
Stratatech Corporation Pipeline Products Summary by Development Stage
EpiReady - Product Status
EpiReady - Product Description
ExpressGraft - Antineoplastic - Product Status
ExpressGraft - Antineoplastic - Product Description
ExpressGraft - Sclerotic Digital Ulcers - Product Status
ExpressGraft - Sclerotic Digital Ulcers - Product Description
ExpressGraft Antimicrobial - Diabetic Foot Ulcers - Product Status
ExpressGraft Antimicrobial - Diabetic Foot Ulcers - Product Description
ExpressGraft Antimicrobial - Venous Leg Ulcers - Product Status
ExpressGraft Antimicrobial - Venous Leg Ulcers - Product Description
ExpressGraft Pro-Angeogenic - Venous Leg Ulcers - Product Status
ExpressGraft Pro-Angeogenic - Venous Leg Ulcers - Product Description
ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers - Product Status
ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers - Product Description
ExpressGraftEnhance Tissue - Product Status
ExpressGraftEnhance Tissue - Product Description
StrataGraft - Epidermolysis Bullosa - Product Status
StrataGraft - Epidermolysis Bullosa - Product Description
StrataGraft - Scar Revision - Product Status
StrataGraft - Scar Revision - Product Description
StrataGraft - Scleroderma Digital Ulcers - Product Status
StrataGraft - Scleroderma Digital Ulcers - Product Description
StrataGraft - Severe Burns - Product Status
StrataGraft - Severe Burns - Product Description
Stratatech Corporation, Key Employees
List of Figures
Stratatech Corporation Pipeline Products by Equipment Type
Stratatech Corporation Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report